Morpho, Inc. (JP:3653)

:3653

3653

Morpho, Inc.

RESEARCH TOOLSreports

Want to see JP:3653 full AI Analyst Report?

Morpho, Inc. (3653) Price & Analysis

3 Followers

3653 Stock Chart & Stats

¥847.00

¥6.00(0.45%)

At close: Jan 08 4:00 PM EST

¥847.00

¥6.00(0.45%)

Day’s Range― - ―

52-Week Range¥609.00 - ¥1,337.00

Previous CloseN/A

Volume29.50K

Average Volume (3M)24.81K

Market Cap

¥3.31B

Enterprise Value¥1.32B

Total Cash (Recent Filing)¥2.53B

Total Debt (Recent Filing)¥10.48M

Price to Earnings (P/E)―

Beta1.12

Next Earnings

Jun 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-14.88

Shares Outstanding5,508,500

10 Day Avg. Volume14,970

30 Day Avg. Volume24,810

Financial Highlights & Ratios

PEG Ratio0.51

Price to Book (P/B)1.36

Price to Sales (P/S)1.46

P/FCF Ratio-132.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance-sheet StrengthVery low leverage and a large equity base give management durable financial flexibility to fund R&D, absorb operating volatility, and pursue strategic partnerships or M&A without relying on external debt, supporting long-term resilience across cycles.

Revenue Momentum & Gross MarginsStrong top-line growth paired with mid-50% gross margins reflects scalable, high-margin software licensing economics. Durable revenue expansion and healthy product-level margins underpin reinvestment capacity and profitability potential as adoption across devices increases.

Licensing-based Business ModelA royalty and licensing model creates recurring, usage-linked revenue and high client stickiness via OEM integrations. Coupled with custom contracts and partnerships across mobile, automotive, security and medical, this diversification supports stable demand over the medium term.

Bears Say

Profitability VolatilityThe company’s earnings profile is inconsistent, moving from healthy profit to loss within a year. Such volatility complicates forecasting, limits sustained returns to shareholders, and raises execution risk for converting revenue growth into stable net income.

Weak Cash GenerationNegative free cash flow and cash-flow deterioration constrain the firm’s ability to fund operations, R&D, and customer projects internally. Persistent weak cash conversion increases dependency on the balance sheet and can limit strategic flexibility over months.

Return-on-equity VolatilityROE swings indicate the company struggles to consistently convert its large equity base into sustainable profits. This undermines long-term shareholder value creation and suggests that capital allocation or operational efficiency needs improvement.

3653 FAQ

What was Morpho, Inc.’s price range in the past 12 months?

Morpho, Inc. lowest stock price was ¥609.00 and its highest was ¥1337.00 in the past 12 months.

What is Morpho, Inc.’s market cap?

Morpho, Inc.’s market cap is ¥3.31B.

When is Morpho, Inc.’s upcoming earnings report date?

Morpho, Inc.’s upcoming earnings report date is Jun 12, 2026 which is tomorrow.

How were Morpho, Inc.’s earnings last quarter?

Morpho, Inc. released its earnings results on Mar 13, 2026. The company reported -¥71.31 earnings per share for the quarter, missing the consensus estimate of N/A by -¥71.31.

Is Morpho, Inc. overvalued?

According to Wall Street analysts Morpho, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Morpho, Inc. pay dividends?

Morpho, Inc. does not currently pay dividends.

What is Morpho, Inc.’s EPS estimate?

Morpho, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Morpho, Inc. have?

Morpho, Inc. has 5,508,500 shares outstanding.

What happened to Morpho, Inc.’s price movement after its last earnings report?

Morpho, Inc. reported an EPS of -¥71.31 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.112%.

Which hedge fund is a major shareholder of Morpho, Inc.?

Currently, no hedge funds are holding shares in JP:3653

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Morpho, Inc.

Morpho, Inc., established in Tokyo, Japan, in 2004, focuses on the research, development, and commercialization of artificial intelligence (AI) and advanced image processing technologies. The company's operations extend globally, encompassing Japan, the United States, China, South Korea, Europe, and various other international markets. Its extensive portfolio of image processing offerings includes features such as stabilization for both still images and video, noise reduction techniques, diverse video generation and processing tools, high dynamic range (HDR) and dynamic range-corrected image creation, panoramic selfie generation, motion vector detection, a comprehensive library of photo effect filters, image super-resolution, frame interpolation, cinemagraph capabilities, and seamless camera transitions during zooming. Furthermore, Morpho provides a range of AI-driven products. These solutions feature a high-speed AI inference engine, AI-enhanced image refinement via segmentation and pixel filtering, human pose estimation, bokeh effect generation using dual cameras, image classification, object detection, single-camera background blurring, precise image segmentation, object tracking, automatic mask and wipe generation, and the development of crucial training data for AI. These cutting-edge technologies are integrated into a wide array of sectors, including smart devices, automotive systems, semiconductor manufacturing, medical products, digital media platforms, and smart city infrastructure.